Shattuck Labs (STTK) Change in Accured Expenses (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Change in Accured Expenses of -$2.0 million for Q1 2026, down 173.04% year-over-year from $2.7 million in Q1 2025, and down 321.66% quarter-over-quarter from $882000.0 in Q4 2025.
Analysis
Shattuck Labs (STTK) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Change in Accured Expenses for 8 consecutive years, with -$2.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 173.04% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$2.7 million (down 25.87% YoY), while the FY2025 annual figure was -$1.4 million, up 57.19% from the prior year.
- Change in Accured Expenses slipped to -$2.0 million in Q1 2026 per STTK's latest filing, from $882000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $4.1 million in Q2 2022 and bottomed at -$7.4 million in Q1 2023.
- Historically, Change in Accured Expenses has averaged -$710764.7 across 5 years, with a median of -$687000.0 in 2025.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses tumbled 1123.96% — and 2024, when it soared 923.12%.
- Shattuck Labs' Change in Accured Expenses stood at $1.9 million in 2022, then plunged by 206.91% to -$2.0 million in 2023, then sank by 45.81% to -$3.0 million in 2024, then surged by 129.64% to $882000.0 in 2025, then plunged by 321.66% to -$2.0 million in 2026.
- Business Quant data shows STTK's Change in Accured Expenses at -$2.0 million in Q1 2026, $882000.0 in Q4 2025, and -$687000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Shattuck Labs | 885.09 Mn | 885.09 Mn | - | 793,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 793,000.00 |
| Mar 31, 2026 | -1.96 Mn |
| Dec 31, 2025 | 882,000.00 |
| Sep 30, 2025 | -687,000.00 |
| Jun 30, 2025 | -921,000.00 |
| Mar 31, 2025 | -716,000.00 |
| Dec 31, 2024 | -2.98 Mn |
| Sep 30, 2024 | -76,000.00 |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | -1.95 Mn |
| Dec 31, 2023 | -2.04 Mn |
| Sep 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | -199,000.00 |
| Mar 31, 2023 | -7.36 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | -2.47 Mn |
| Jun 30, 2022 | 4.14 Mn |
| Mar 31, 2022 | -601,000.00 |
| Dec 31, 2021 | 493,000.00 |
| Sep 30, 2021 | 2.46 Mn |